Tuesday, 29 December 2020

: Arcturus Therapeutics shares slide 37% in premarket after COVID vaccine data are deemed ‘underwhelming’

Labels:

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home